Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06289699

Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures

Alert Frequency, Nurse, and Patient Satisfaction With a Continuous Wireless Vital Sign Monitoring Software Across Health Care Systems and Cultures

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Christian S. Meyhoff · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this prospective, international multi-centre pilot study is to assess the functionality and user experience of a new vital sign monitoring system in 20 patients and 20 nurses in the general ward at each centre. The patients will be monitored with a wireless, continuous vital sign monitoring systems and answer a questionnaire afterwards. They will in addition have vital signs monitored as per standard practice. The nurses will answer a questionnaire after having had the responsibility for a monitored patient for a full shift. The main aims are: To determine the frequency of alerts activated in the app in relation to the alerts that should be activated based on measured data, to explore current practices of in-hospital monitoring by semi-structured interviews to map differences across systems and to test nurse and patient satisfaction.

Detailed description

The participants will be monitored for 4 days postoperatively or for 4 days after acute admission and until discharge. Monitoring devices used in this study will be validated FDA or/and CE approved devices used within their original purpose. Centers can choose to use Sotera Visimobile or Isansys Lifeguard with accompanying sensors. These devices will be used together with the CE approved WARD web and mobile application. Study sites include: St. Olav Hospital Trondheim, Royal Liverpool University Hospital, University Medical Centre Hamburg-Eppendorf,University Medical Centre Groningen, The Netherlands and the Cleveland Clinic.

Conditions

Timeline

Start date
2024-02-26
Primary completion
2026-08-01
Completion
2026-12-31
First posted
2024-03-04
Last updated
2025-08-12

Locations

5 sites across 5 countries: United States, Germany, Netherlands, Norway, United Kingdom

Source: ClinicalTrials.gov record NCT06289699. Inclusion in this directory is not an endorsement.